Skip to main content

Table 5 Risk of endomyocardial biopsy (EMB) complications reported in previous studies

From: Endomyocardial biopsy via the femoral access - still safe and valuable diagnostic tool

Author (year)

Number of biopsies

Overall complications rate (%)

Major complications rate

Minor complications rate

Reference

Deckers (1992)

546

6

1.2a

4.8a

[24]

Hiramitasu (1998)

19 964

 

0.7

 

[25]

Felker (1999)

323

 

0.32

 

[26]

Holzmann (2008)

3048

1.25a

0.1a

1.15a

[12]

Yilmaz (2010)

622 (LVEMB)

3.5 (LVEMB)

0.6 (LVEMB)

2.9 (LVEMB)

[13]

490 (RVEMB)

5.9 (RV EMB)

0.8 (RVEMB)

5.1 (RVEMB)

Huang (2010)

439

1.61

0.0

1.61

[27]

Saraiva (2011)

2217

0.71

-

-

[14]

Fiorelli (2012)

5347

6.2

0.3

5.9

[28]

Bennet (2013)

851

1.9

0.9

1.0

[16]

Jang (2013)

228

9.2

1.3

7.9

[15]

Chimenti (2013)

3549 (LVEMB)

2.33 (LVEMB)

0.33 (LVEMB)

2.0 (LVEMB)

[22]

3068 (RVEMB)

1.8 (RVEMB)

0.45 (RVEMB)

1.35 (LVEMB)

Strecker (2013)

1896

 

1.0

 

[21]

Isogai (2015)

9508

 

0.98

 

[19]

Schulz (2015))~

37

2.7

0

2.7

[1]

Schäufele (2015)~

41

0

0

0

[23]

  1. avalues calculated on the basis of the manuscript data; LVEMB- left ventricle endomyocardial biopsy; RVEMB-right ventricle endomyocardial biopsy; ~ - transradial approach